Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease

from Thorax Podcast · host BMJ Group

In this podcast Dr Janice Higginson talks to Dr Helena Anderson from Oslo University Hospital about her recent paper published in Rheumatology. The paper is a retrospective review of research done into rituximab's effect on the rare Antisynthetase Syndrome.

Episode metadata supplied by the publisher feed · Published Sep 29, 2015

Embed this episode

Attribution link and audio player

NOW PLAYING

Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease

0:00 9:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Thorax Podcast?

This episode is 9 minutes long.

When was this Thorax Podcast episode published?

This episode was published on September 29, 2015.

Can I download this Thorax Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!